Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers

Background: Most of the patients with Pancreatic Ductal Adenocarcinoma (PDA) are not eligible for a curative surgical resection. For this reason there is an urgent need for personalized therapies. PDA is the result of complex interactions between tumor molecular profile and metabolites produced by i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Oncol
Hauptverfasser: Follia, Laura, Ferrero, Giulio, Mandili, Giorgia, Beccuti, Marco, Giordano, Daniele, Spadi, Rosella, Satolli, Maria Antonietta, Evangelista, Andrea, Katayama, Hiroyuki, Hong, Wang, Momin, Amin A., Capello, Michela, Hanash, Samir M., Novelli, Francesco, Cordero, Francesca
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2019
Schlagworte:
Oncology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400843/
https://ncbi.nlm.nih.gov/pubmed/30873387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00115
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge